Sulfonamides as antiinflammatory agents in the treatment of wegener's granulomatosis
Open Access
- 1 October 1990
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 33 (10), 1590-1593
- https://doi.org/10.1002/art.1780331020
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Anticytoplasmic Autoantibodies in the Diagnosis and Follow-Up of Wegener's GranulomatosisMayo Clinic Proceedings, 1989
- Wegener's Granulomatosis: Observations on Treatment With Antimicrobial AgentsMayo Clinic Proceedings, 1985
- Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.JCI Insight, 1982
- Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1981
- Sulfones and sulfonamides in dermatology todayJournal of the American Academy of Dermatology, 1979
- Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsoneBritish Journal of Dermatology, 1978
- The Inhibition of Polymorphonuclear Leukocyte Cytotoxicity by DapsoneJCI Insight, 1978
- Effect Of Sulfones On Complement Deposition In Dermatitis Herpetiformis And On Complement-Mediated Guinea-Pig ReactionsJournal of Investigative Dermatology, 1976
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965
- Sensitivity to Iodides and Bromides in Dermatoses other than Dermatitis Herpetiformis11From the New York Skin and Cancer Unit, New York Post-Graduate Medical School and Hospital, Columbia University.Journal of Investigative Dermatology, 1947